Approval · Notice of Compliance 19399 · 2017
METHOTREXATE TABLETS, USP: Notice of Compliance 19399
Issued June 9, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 19399
- Date
- June 9, 2017
- Company
- Hospira Healthcare CorporationKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Revisions to the product monograph
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| METHOTREXATE TABLETS, USP | Not yet assigned | — |
Medicinal ingredients
- METHOTREXATE 10 MG per TAB